 |
 |
 |
Search IPO GMP:
Avience Biomedicals IPO GMP
Avience Biomedicals IPO is an SME IPO, the company will raise up to 30 crore 23 lakh 90 thousand 4 hundred rupees for 14,53,800 shares. The IPO comprises a fresh issue of 14,53,800 shares (aggregating up to 30 crore 23 lakh 90 thousand 4 hundred rupees), and an offer for sale (OFS) of NIL.
| Avience Biomedicals IPO GMP (Grey Market Premium) | |
| Premium From IPO Cut-off Price | |
| IPO Price Band | ₹196 to ₹208 per share |
Avience Biomedicals IPO Latest GMP (Grey Market Premium) Today
Visit us daily to get the latest update on IPO GMP. You will get the latest update of SME IPO GMP.
Avience Biomedicals IPO Lates GMP (grey market premium) available here
- Price Band of Avience Biomedicals IPO is ₹196 to ₹208 per share.
- Current GMP (Grey Market Premium) for Avience Biomedicals IPO is:
- It is a premium for the IPO cut-off price .
- As per Avience Biomedicals IPO Taday’s GMP Data, the estimated listing price of Avience Biomedicals IPO shares can be:
- Estimated listing price calculated as Avience Biomedicals IPO cutoff price or allotment price: ₹208 per share + IPO current GMP: .
Avience Biomedicals SME IPO GMP |
||
| Date | GMP (₹) | Listing Price (₹-Estimated) |
| Today | 140 | |
| 25 June 2026 | 140 | |
| 24 June 2026 | 140 | |
| 23 June 2026 | 140 | |
| 22 June 2026 | 70 | |
| 21 June 2026 | 70 | |
| 20 June 2026 | 70 | |
| 19 June 2026 | 63 | |
| 18 June 2026 | 40 | |
| 17 June 2026 | 40 | |
| 16 June 2026 | 65 | |
| 15 June 2026 | 50 | |
Total shares offered by Avience Biomedicals IPO is 14,53,800 shares (aggregating up to 30 crore 23 lakh 90 thousand 4 hundred rupees). Out of which 4,81,200 shares (33.10%) is reserved for retail, 2,07,000 shares (14.24%) is reserved for HNI (NII), 6,83,400 shares (47.01%) is reserved for QIB, and 82,200 shares (5.65%) is reserved for market maker Asnani Stock Broker Pvt Ltd.
Avience Biomedicals IPO will open for subscription on 18 June 2026 and close on 22 June 2026. Basis of allotment will be decided on 23 June 2026, initiation of refund will begin on 24 June 2026 and finally IPO will be listed on 25 June 2026 at NSE SME. Fintellectual Corporate Advisors Pvt Ltd is the book running lead manager and Skyline Financial Services Pvt Ltd is the registrar of the Avience Biomedicals IPO.
Avience Biomedicals IPO Price Band and Market Lot
Avience Biomedicals has set a price band of ₹196 to ₹208 per share and lot size is of . Retail investors can bid for a minimum and maximum of 2 lots (1,200 shares), requiring an investment of ₹2,49,600, sHNI investors can bid for a minimum of 3 lots (1,800 shares), requiring an investment of ₹3,74,400 and bHNI investors can bid for a minimum of 9 Lots (5,400 shares), requiring an investment of ₹11,23,200 calculated at the cut-off price ₹208 per share (the upper end of the price band).
| Avience Biomedicals IPO Price | |
| Face Value | ₹10 per share |
| Price Band | ₹196 to ₹208 per share |
| Lot Size | 600 shares |
| IPO Issue Type | Book Built Issue |
About Avience Biomedicals
Incorporated on June 2024, based in Delhi, Avience Biomedicals Limited is a molecular diagnostics company specializing in manufacturing, supplying, and exporting advanced diagnostic solutions in the biotechnology, genomics, and IVD (In Vitro Diagnostics) industry.Avience Biomedicals IPO GMP FAQs
The latest Grey Market Premium (GMP) of Avience Biomedicals IPO is .
It is a premium to the IPO cut-off price Avience Biomedicals. GMP gives a rough estimate of the premium at which the stock might list. It’s not guaranteed but often aligns with market sentiment.
As per latest GMP data, the expected return for Avience Biomedicals IPO can be .
Expected listing listing price for Avience Biomedicals share can be .
According to latest GMP data pattern expected listing price and profit per share for Avience Biomedicals IPO can be . Expected listing price is calculated by adding the GMP to the IPO issue price. Estimated listing price = IPO issue price + current GMP. This value changes as the GMP fluctuates.
GMP is an unofficial indicator and can be manipulated. It should never be the sole reason to apply. Always consider fundamentals and risk tolerance. Subscription demand, financial performance, market sentiment, peer valuation, and overall liquidity can impact the GMP trend.
Grey Market Premium (GMP) refers to the unofficial over-the-counter market where IPO shares or applications are traded before listing on stock exchanges. GMP data is based on market speculation, demand, subscriptions, and market sentiment, and may change rapidly without notice. Since the grey market is unregulated, GMP figures may be volatile, inaccurate, or subject to manipulation.
GMP should not be considered the sole basis for making investment decisions. The information provided by MarketBandhu is for informational purposes only (gathered from various sources) and does not constitute financial, investment, or trading advice. MarketBandhu does not recommend buying, selling, or subscribing to any IPO based solely on GMP data.